Ethyl 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylate, 95.0%, 5g

anti-Keratin K17 mouse monoclonal, Ks17.E3, 1 ml

Methyl 2-chloro-1,3-benzoxazole-5-carboxylate, 95+%, 250mg

2H-Chromene-3-carboxylic acid, 95.0%, 10g

[4-(Isopropylsulfonyl)phenyl]acetic acid, 95.0%, 500mg

(R)-2-Aminohexanoic acid, 95.0%, 10g

4-(Methylsulfonyl)phenylhydrazine, 95.0%, 10g

3-Bromo-2-methyl-6-(1-methyl-5-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-1,2,3-triazol-4-yl)pyridine, 98%, 500mg

6,8-Dibromoimidazo[1,2-a]pyrazine>98.0%(GC)1g

(S)-2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)ethanamine hydrochloride, 98%, 250mg

Ethyl 4-Bromo-3-methylbenzoate>98.0%(GC)25g

1-[(4-isopropylphenoxy)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 250mg

4-Methoxy-3-nitrobenzaldehyde, 97.0%, 10g